# Tenax Therapeutics, Inc.: Form 8-K, filed Dec 4, 2024

- Company: [Tenax Therapeutics, Inc.](/companies/tenx.md) (CIK 34956)
- Form: 8-K
- Filed: 2024-12-04
- Accepted by EDGAR: Dec 4, 2024, 17:16 ET
- Period: 2024-12-02
- Accession: 0001654954-24-015161
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/34956/000165495424015161/tenx_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/34956/000165495424015161/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/34956/000165495424015161/tenx_8k.htm

Filed Dec 4, 2024.
Source: SEC EDGAR, the filing index for accession 0001654954-24-015161. Last ingested by Listed: Nov 12, 2026, 19:31 ET. No prices; not investment advice.
